Showing results (2061-2070 of 2,720) with videos related to

Sort By:
Pageof 272
Journal of Personality and Social Psychology|December 15, 2022
A three-dimensional taxonomy of achievement emotionsReinhard Pekrun, Herbert W Marsh, Andrew J Elliot, et al.
Tomography (Ann Arbor, Mich.)|July 27, 2022
Photon-Counting Detector CT Virtual Monoengergetic Images for Cochlear Implant Visualization-A Head to Head Comparison to Energy-Integrating Detector CTStephan Waldeck, Daniel Overhoff, Leona Alizadeh, et al.
Human Immunology|August 3, 2018
The portal vein as a distinct immunological compartment - A comprehensive immune phenotyping studyAlexander Queck, Sabrina Rueschenbaum, Alica Kubesch, et al.
European Journal of Radiology|August 29, 2018
Dual-energy CT in patients with colorectal cancer: Improved assessment of hypoattenuating liver metastases using noise-optimized virtual monoenergetic imagingLukas Lenga, Rouben Czwikla, Julian L Wichmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 19, 2022
Systemic Activation of Neutrophils by Immune Complexes Is Critical to IgA VasculitisSarah Mayer-Hain, Kathleen Gebhardt, Matthias Neufeld, et al.
European Journal of Clinical Investigation|December 8, 2023
Imaging-based risk stratification of patients with pulmonary embolism based on dual-energy CT-derived radiomicsJennifer Gotta, Vitali Koch, Tobias Geyer, et al.
Diagnostics (Basel, Switzerland)|June 28, 2023
Dual-Energy CT in Cardiothoracic Imaging: Current DevelopmentsLeona S Alizadeh, Thomas J Vogl, Stephan S Waldeck, et al.
Investigative Radiology|June 24, 2005
Evaluation of the stereotactic 8G vacuum-assisted breast biopsy in the histologic evaluation of suspicious mammography findings (BI-RADS IV)Thomas Diebold, Tanja Hahn, Christine Solbach, et al.
European Radiology|February 25, 2003
Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative USThomas J Vogl, Wolfram Schwarz, Stefan Blume, et al.
Investigational New Drugs|June 1, 1988
Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinomaP J Elson, L K Kvols, S E Vogl, et al.
Pageof 272